Return to the Global home page

HSBC Republic offers four hedge funds in Switzerland

Press release, 5 May 2003

Geneva, May 2 -- HSBC Republic Bank (Suisse) SA has registered four new funds of hedge funds in Switzerland: The HSBC Republic GH Fund, HSBC Republic Multi-Adviser Arbitrage Fund, HSBC Republic Emerging Markets H Fund and the HSBC Republic Zenith Technology Fund. HSBC Republic first entered the hedge fund market in 1989. Today, HSBC Republic boasts client assets invested in alternative investments of more than US Dollar 10 billion and has a strong record in delivering attractive returns with good control of volatility.

HSBC Republic has three hedge fund research teams working together in Europe and the United States, demonstrating our strong commitment to research and analysis in alternative investments. We are a leading intermediary in the sector and have close contacts with the key sector participants. HSBC Republic is the named investor in some 800 hedge funds and, in total, our research teams monitor in excess of 1,000 hedge funds.

The four fund of hedge funds recently registered in Switzerland focus on the following strategies:

Arbitrage and Relative Value
The HSBC Republic Multi-Adviser Arbitrage Fund is a good example of results achieved in this category. With a track record that has outperformed global government bonds, with lower volatility, this vehicle has been used successfully in several bond portfolios.

Macro/Commodity Trading Advisors strategies
A large portion of the HSBC Republic GH Fund (global hedge) is invested in fixed income, equities, financial and commodities futures. Managers using these strategies have been able to deliver high levels of returns during the difficult markets of 2000 through to 2002.

Emerging markets
The HSBC Republic Emerging Markets H Fund is a specialist fund which aims to deliver attractive positive performance focusing on developing economies. Over the period 1996 to 2002, many emerging market hedge funds have delivered attractive positive performance while the underlying emerging equity markets have shown large declines.

Technology/Biotechnology
The HSBC Republic Zenith Technology Fund offers exposure to the life sciences, telecommunication and health care sectors, protecting client capital at a time when technology stocks have shown severe declines.

More articles in Pressroom

Sponsorship and events

About you

Find out what HSBC Private Bank can do for you:

Our services